Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enzo Biochem (ENZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 306,922
  • Shares Outstanding, K 46,930
  • Annual Sales, $ 107,800 K
  • Annual Income, $ -2,500 K
  • 36-Month Beta 1.06
  • Price/Sales 2.85
  • Price/Cash Flow 279.47
  • Price/Book 3.49

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.95 +10.42%
on 05/01/18
6.89 -4.64%
on 05/18/18
+0.47 (+7.70%)
since 04/25/18
3-Month
5.35 +22.80%
on 03/29/18
7.36 -10.67%
on 03/12/18
-0.19 (-2.81%)
since 02/23/18
52-Week
5.35 +22.80%
on 03/29/18
12.04 -45.43%
on 07/14/17
-2.48 (-27.40%)
since 05/25/17

Most Recent Stories

More News
Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case

Enzo Biochem, Inc. (NYSE:ENZ) and its subsidiary Enzo Life Sciences, Inc. today announced that the Patent Trial and Appeal Board has denied a petition filed by Hologic, Inc. (NASDAQ:HOLX)...

ENZ : 6.57 (+0.46%)
HOLX : 38.92 (+0.52%)
Exploring Fundamental Drivers Behind Enzo Biochem, RPX, The Hackett Group, 2U, AK Steel Holding, and Och-Ziff Capital Management Group -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enzo Biochem, Inc. (NYSE:ENZ),...

ENZ : 6.57 (+0.46%)
OZM : 2.10 (-0.47%)
HCKT : 16.12 (-0.92%)
AKS : 4.47 (-0.89%)
TWOU : 91.32 (+2.84%)
RPXC : 10.45 (-0.19%)
Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics company, announced today validation of a cervical cancer biomarker detection test that provides a highly robust and cost-efficient...

ENZ : 6.57 (+0.46%)
Free Post Earnings Research Report: Enzo Biochem's Revenue Grew 5%; Net Loss Narrowed

LONDON, UK / ACCESSWIRE / January 09, 2018 / Active-Investors.com has just released a free earnings report on Enzo Biochem, Inc. (NYSE: ENZ). If you want access to this report all you need to do is sign...

ENZ : 6.57 (+0.46%)
Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allstate Corporation (NYSE:ALL),...

ENZ : 6.57 (+0.46%)
ALL : 95.45 (-0.07%)
MCRB : 8.35 (+3.73%)
AHP : 10.38 (+0.29%)
SPGI : 200.36 (+0.27%)
HF : 35.34 (+0.20%)
Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas

Stock Monitor: Enzo Biochem Post Earnings Reporting

ENZ : 6.57 (+0.46%)
CGIX : 1.03 (+5.10%)
Enzo Biochem, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / December 8, 2017 / Enzo Biochem, Inc. (NYSE: ENZ) will be discussing their earnings results in their Q1 Earnings Call to be held on December 8, 2017 at 8:30 AM Eastern Time....

ENZ : 6.57 (+0.46%)
Enzo Biochem Reports Improved First Quarter Results

--Outlook Buoyed by Successful Product Developments, Especially Women's Health Panel

ENZ : 6.57 (+0.46%)
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2018 Results Friday, December 8, 2017 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 first quarter results Friday, December 8, 2017, at 8:30 AM E.T.

ENZ : 6.57 (+0.46%)
Enzo Biochem Announces NYS Department of Health's Approval of a New Women's Health Infectious Disease Panel

--Furthers Enzo's Development Program of Robust, Medically Relevant & Affordable Molecular Diagnostic Products and Services Addressing the Clinical Lab Industry's Financial Pressures

ENZ : 6.57 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade ENZ with:

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

2nd Resistance Point 6.70
1st Resistance Point 6.64
Last Price 6.57
1st Support Level 6.52
2nd Support Level 6.46

See More

52-Week High 12.04
Fibonacci 61.8% 9.48
Fibonacci 50% 8.69
Fibonacci 38.2% 7.91
Last Price 6.57
52-Week Low 5.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar